1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Prosight Management, LP Buys Alexion Pharmaceuticals Inc, Direxion Small Cap Bear 3X Shares, Cue Biopharma Inc, Sells Arqule Inc, United Therapeutics Corp, Biomarin Pharmaceutical Inc

Investment company Prosight Management, LP (Current Portfolio) buys Alexion Pharmaceuticals Inc, Direxion Small Cap Bear 3X Shares, Cue Biopharma Inc, Change Healthcare Inc, Iovance Biotherapeutics Inc, sells Arqule Inc, United Therapeutics Corp, Biomarin Pharmaceutical Inc, Envista Holdings Corp, Strongbridge Biopharma PLC during the 3-months ended 2020Q1, according to the most recent filings of the investment company, Prosight Management, LP. As of 2020Q1, Prosight Management, LP owns 41 stocks with a total value of $211 million. These are the details of the buys and sells.

For the details of Prosight Management, LP's stock buys and sells, go to https://www.gurufocus.com/guru/prosight+management%2C+lp/current-portfolio/portfolio

These are the top 5 holdings of Prosight Management, LP
  1. Arena Pharmaceuticals Inc (ARNA) - 419,602 shares, 8.36% of the total portfolio. Shares added by 27.88%
  2. Iovance Biotherapeutics Inc (IOVA) - 553,100 shares, 7.86% of the total portfolio. Shares added by 42.33%
  3. Kura Oncology Inc (KURA) - 1,450,000 shares, 6.85% of the total portfolio. Shares added by 39.96%
  4. Alexion Pharmaceuticals Inc (ALXN) - 140,000 shares, 5.97% of the total portfolio. New Position
  5. uniQure NV (QURE) - 245,564 shares, 5.53% of the total portfolio. Shares added by 3.40%
New Purchase: Alexion Pharmaceuticals Inc (ALXN)

Prosight Management, LP initiated holding in Alexion Pharmaceuticals Inc. The purchase prices were between $75.56 and $113.92, with an estimated average price of $98.6. The stock is now traded at around $100.92. The impact to a portfolio due to this purchase was 5.97%. The holding were 140,000 shares as of .

New Purchase: Direxion Small Cap Bear 3X Shares (TZA)

Prosight Management, LP initiated holding in Direxion Small Cap Bear 3X Shares. The purchase prices were between $32.83 and $105.52, with an estimated average price of $47.04. The stock is now traded at around $38.42. The impact to a portfolio due to this purchase was 3.52%. The holding were 125,000 shares as of .

New Purchase: Change Healthcare Inc (CHNG)

Prosight Management, LP initiated holding in Change Healthcare Inc. The purchase prices were between $6.86 and $17.26, with an estimated average price of $14.09. The stock is now traded at around $10.68. The impact to a portfolio due to this purchase was 2.65%. The holding were 559,125 shares as of .

New Purchase: LHC Group Inc (LHCG)

Prosight Management, LP initiated holding in LHC Group Inc. The purchase prices were between $104.81 and $158.93, with an estimated average price of $139.65. The stock is now traded at around $145.49. The impact to a portfolio due to this purchase was 2.32%. The holding were 34,909 shares as of .

New Purchase: AMN Healthcare Services Inc (AMN)

Prosight Management, LP initiated holding in AMN Healthcare Services Inc. The purchase prices were between $48.28 and $81.99, with an estimated average price of $68.47. The stock is now traded at around $40.33. The impact to a portfolio due to this purchase was 2.29%. The holding were 83,471 shares as of .

New Purchase: Zogenix Inc (ZGNX)

Prosight Management, LP initiated holding in Zogenix Inc. The purchase prices were between $17.8 and $56.59, with an estimated average price of $36.87. The stock is now traded at around $26.30. The impact to a portfolio due to this purchase was 1.92%. The holding were 163,708 shares as of .

Added: Cue Biopharma Inc (CUE)

Prosight Management, LP added to a holding in Cue Biopharma Inc by 301.12%. The purchase prices were between $9.85 and $22.27, with an estimated average price of $16.16. The stock is now traded at around $25.62. The impact to a portfolio due to this purchase was 2.79%. The holding were 552,060 shares as of .

Added: Iovance Biotherapeutics Inc (IOVA)

Prosight Management, LP added to a holding in Iovance Biotherapeutics Inc by 42.33%. The purchase prices were between $19.54 and $38.85, with an estimated average price of $26.44. The stock is now traded at around $35.37. The impact to a portfolio due to this purchase was 2.34%. The holding were 553,100 shares as of .

Added: Cigna Corp (CI)

Prosight Management, LP added to a holding in Cigna Corp by 228.78%. The purchase prices were between $130.06 and $222.56, with an estimated average price of $194.84. The stock is now traded at around $184.46. The impact to a portfolio due to this purchase was 2.17%. The holding were 37,129 shares as of .

Added: Kura Oncology Inc (KURA)

Prosight Management, LP added to a holding in Kura Oncology Inc by 39.96%. The purchase prices were between $6.45 and $14.04, with an estimated average price of $11.51. The stock is now traded at around $14.38. The impact to a portfolio due to this purchase was 1.96%. The holding were 1,450,000 shares as of .

Added: Arena Pharmaceuticals Inc (ARNA)

Prosight Management, LP added to a holding in Arena Pharmaceuticals Inc by 27.88%. The purchase prices were between $34.83 and $54.15, with an estimated average price of $45.98. The stock is now traded at around $45.26. The impact to a portfolio due to this purchase was 1.82%. The holding were 419,602 shares as of .

Added: Aldeyra Therapeutics Inc (ALDX)

Prosight Management, LP added to a holding in Aldeyra Therapeutics Inc by 42.50%. The purchase prices were between $1.62 and $6.4, with an estimated average price of $4.55. The stock is now traded at around $3.75. The impact to a portfolio due to this purchase was 0.71%. The holding were 2,035,340 shares as of .

Sold Out: Arqule Inc (ARQL)

Prosight Management, LP sold out a holding in Arqule Inc. The sale prices were between $19.96 and $20.04, with an estimated average price of $20.

Sold Out: Strongbridge Biopharma PLC (SBBP)

Prosight Management, LP sold out a holding in Strongbridge Biopharma PLC. The sale prices were between $1.57 and $3.51, with an estimated average price of $2.6.

Sold Out: R1 RCM Inc (RCM)

Prosight Management, LP sold out a holding in R1 RCM Inc. The sale prices were between $7.57 and $13.91, with an estimated average price of $12.08.

Sold Out: Evolent Health Inc (EVH)

Prosight Management, LP sold out a holding in Evolent Health Inc. The sale prices were between $3.64 and $11.77, with an estimated average price of $9.01.

Sold Out: Molecular Templates Inc (MTEM)

Prosight Management, LP sold out a holding in Molecular Templates Inc. The sale prices were between $11.31 and $18.26, with an estimated average price of $14.57.

Sold Out: Paratek Pharmaceuticals Inc (PRTK)

Prosight Management, LP sold out a holding in Paratek Pharmaceuticals Inc. The sale prices were between $2.67 and $4.97, with an estimated average price of $3.69.



Here is the complete portfolio of Prosight Management, LP. Also check out:

1. Prosight Management, LP's Undervalued Stocks
2. Prosight Management, LP's Top Growth Companies, and
3. Prosight Management, LP's High Yield stocks
4. Stocks that Prosight Management, LP keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:



Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)